RIM-BP2 Activators
RIM-BP2 activators constitute a group of chemical compounds that indirectly augment the functional activity of RIM-BP2, each exerting its influence through distinct signaling pathways and cellular mechanisms. Forskolin and Rolipram, for example, enhance RIM-BP2 function by increasing intracellular cAMP levels, subsequently activating PKA. This kinase is poised to phosphorylate synaptic proteins, potentially bolstering RIM-BP2's role in the synaptic vesicle cycle. PMA, through PKC activation, may similarly modify synaptic proteins, enhancing RIM-BP2's scaffolding functions, crucial for neurotransmitter release. BAY K 8644 and Ionomycin elevate intracellular calcium levels, which is pivotal for synaptic protein interactions and might thereby enhance RIM-BP2's activity in synaptic transmission, while Diazoxide, by modulating membrane potential, could indirectly heighten RIM-BP2's contribution to synaptic vesicle exocytosis.
The action of activators such as Epigallocatechin gallate and Tetrodotoxin underscores the nuanced interplay between kinase inhibition and neuronal excitability in modulating RIM-BP2 activity. EGCG, by inhibiting competitive kinases, may facilitate RIM-BP2-mediated synaptic functions, whereas Tetrodotoxin, a sodium channel blocker, fine-tunes neuronal activity, potentially affecting RIM-BP2's role in synaptic protein dynamics. Furthermore, the regulation of cytoskeletal elements by NSC 23766 through Rac1 GTPase inhibition, could lead to alterations in synaptic vesicle dynamics and neurotransmitter release, processes in which RIM-BP2 is inherently involved. Sphingosine-1-phosphate and FTY720 modulate synaptic transmission and plasticity, further potentiating the role of RIM-BP2 in these processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate proteins including those associated with the synaptic vesicle cycle, potentially enhancing RIM-BP2 functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator. PKC can modify synaptic proteins and their interactions. Through this mechanism, PMA could enhance the functional activity of RIM-BP2 by affecting proteins within its signaling network. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P binds to its receptors and activates G-protein coupled signaling cascades. This can lead to cytoskeletal rearrangements affecting synaptic structure, possibly enhancing the scaffolding functions of RIM-BP2 at the synapse. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
BAY K 8644 acts as a L-type calcium channel agonist, leading to increased calcium influx. Calcium signaling can modulate synaptic protein interactions, which may enhance the activity of RIM-BP2 in synaptic transmission. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor with antioxidant properties. By inhibiting certain kinases, it could reduce competitive signaling, potentially allowing for enhanced RIM-BP2-mediated synaptic activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration. This elevation in calcium may enhance the activity of calcium-dependent proteins and interactions, indirectly leading to enhanced RIM-BP2 activity in neurons. | ||||||
Diazoxide | 364-98-7 | sc-200980 | 1 g | $300.00 | 5 | |
Diazoxide opens ATP-sensitive potassium channels, affecting membrane potential and neuronal excitability. This may indirectly enhance RIM-BP2's role in synaptic vesicle exocytosis by modulating the electrical properties of neurons. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4, leading to increased cAMP levels. This can enhance PKA activity, which may phosphorylate substrates that interact with or regulate RIM-BP2 function. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
FTY720, after phosphorylation, acts as an S1P receptor modulator. It can influence synaptic transmission and plasticity, which may indirectly enhance the synaptic functions where RIM-BP2 is involved. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
NSC 23766 inhibits Rac1 GTPase activity, affecting actin cytoskeleton dynamics. Since RIM-BP2 is involved in synaptic vesicle exocytosis, alterations in the actin cytoskeleton could modulate RIM-BP2's activity at the synapse. | ||||||